文献速递骨质疏松与钙磷/甲状旁腺

维生素D3与骨化二醇纠正维生素D缺乏对粪便微生物组的初步试验

Pilot Trial of Vitamin D3 and Calcifediol in Healthy Vitamin D Deficient Adults: Does It Change the Fecal Microbiome?
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该初步试验纳入18名维生素D缺乏(25(OH)D<20 ng/mL)健康成人,分别每日补充60 µg维生素D3或20 µg 25(OH)D3共8周。两种制剂均显著提升血清25(OH)D等指标,但粪便微生物α多样性、β多样性及菌属丰度均无持续改变,提示纠正维生素D缺乏未带来持久的肠道菌群变化。

要点

  • 维生素D3 60 µg/日或25(OH)D3 20 µg/日共8周可显著提升血清25(OH)D水平。
  • 两种补充剂均未使粪便微生物α多样性或β多样性发生改变。
  • 厚壁菌门与拟杆菌门相对丰度仅4周时短暂变化,研究结束时回到基线。

核心结论

  • 在维生素D缺乏健康成人小样本中,用维生素D3或25(OH)D3恢复维生素D充足未导致粪便微生物组持久改变。

研究设计与样本

  • 初步试验,18名25(OH)D<20 ng/mL的维生素D缺乏成人,随机接受60 µg/日维生素D3或20 µg/日25(OH)D3共8周。
  • 用16S rRNA基因测序刻画粪便微生物组成,评估α多样性(Chao 1、Faith's Phylogenetic Diversity、Shannon指数)、β多样性(DEICODE)及属水平丰度(DESeq2)。

主要发现

  • 维生素D3组8周后平均25(OH)D由17.8升至30.1 ng/mL(P=.002),24,25(OH)2D由1.1升至2.7 ng/mL(P=.003),1,25(OH)2D由49.5至53.0 pg/mL(P=.9)无显著变化。
  • 25(OH)D3组8周后平均25(OH)D由16.7升至50.6 ng/mL(P<.0001),24,25(OH)2D由1.3升至6.2 ng/mL(P=.0001),1,25(OH)2D由56.5升至74.2 pg/mL(P=.05)。
  • 两组粪便微生物α多样性与β多样性均未改变;厚壁菌门平均相对丰度从基线至4周升高、拟杆菌门降低,但研究完成时回到基线。
  • DESeq2分析未确认任何有统计学意义的分类学变化。

临床怎么用

  • 对维生素D缺乏成人,补充维生素D3或25(OH)D3以纠正缺乏可作为常规做法,但不应期待通过此途径持久的肠道菌群改善。
  • 若以肠道菌群为治疗目标,现有证据不支持单纯补充维生素D3或25(OH)D3。
  • 监测疗效时可关注血清25(OH)D与24,25(OH)2D变化,1,25(OH)2D在维生素D3组未显著上升。

局限性

  • 样本量小(18人),为初步试验,统计效能有限。
  • 补充时长仅8周,未评估更长疗程或更高剂量的影响。
  • 研究对象为健康维生素D缺乏成人,结果不宜外推至其他人群或疾病状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Experimental studies suggest that vitamin D receptor signaling may benefit the gut microbiome. In humans, whether vitamin D supplementation directly alters the gut microbiome is not well studied. OBJECTIVE: To determine whether correcting vitamin D deficiency with cholecalciferol (vitamin D3, D3) or calcifediol (25-hydroxyvitamin D3, 25(OH)D3) changes gut microbiome composition. METHODS: 18 adults with vitamin D deficiency (25-hydroxyvitamin D [25(OH)D] <20 ng/mL) received 60 µg/day of D3 or 20 µg/day of 25(OH)D3 for 8 weeks. Changes in serum 25(OH)D, 1,25-diydroxyvitamin D (1,25(OH)2D), and 24,25-dihydroxyvitamin D (24,25(OH)2D) were assessed. We characterized composition of the fecal microbiota using 16S rRNA gene sequencing, and examined changes in α-diversity (Chao 1, Faith's Phylogenetic Diversity, Shannon Index), β-diversity (DEICODE), and genus-level abundances (DESeq2). RESULTS: Vitamin D3 and 25(OH)D3 groups were similar. After 8 weeks of vitamin D3, mean 25(OH)D and 24,25(OH)2D increased significantly, but 1,25(OH)2D did not (25(OH)D: 17.8-30.1 ng/mL, P = .002; 24,25(OH)2D: 1.1 to 2.7 ng/mL, P =0.003; 1,25(OH)2D: 49.5-53.0 pg/mL, P = .9). After 8 weeks of 25(OH)D3, mean 25(OH)D, 24,25(OH)2D, and 1,25(OH)2D increased significantly (25(OH)D: 16.7-50.6 ng/mL, P < .0001; 24,25(OH)2D: 1.3-6.2 ng/mL, P = .0001; 1,25(OH)2D: 56.5-74.2 pg/mL, P = .05). Fecal microbial α-diversity and β-diversity did not change with D3 or 25D3 supplementation. Mean relative abundance of Firmicutes increased and mean relative abundance of Bacterioidetes decreased from baseline to 4 weeks, but returned to baseline by study completion. DESeq2 analysis did not confirm any statistically significant taxonomic changes. CONCLUSION: In a small sample of healthy adults with vitamin D deficiency, restoration of vitamin D sufficiency with vitamin D3 or 25(OH)D3 did not lead to lasting changes in the fecal microbiota.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Shieh A, Lee SM, Lagishetty V, et al. Pilot Trial of Vitamin D3 and Calcifediol in Healthy Vitamin D Deficient Adults: Does It Change the Fecal Microbiome? J Clin Endocrinol Metab. 2021. PMID: 34343292. doi:10.1210/clinem/dgab573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。